Asthma

The Asthma pipeline: 78 tracked drugs, 33 approved for this indication.

33 approved / phase 413 Phase 33 Phase 2/317 Phase 29 Phase 13 preclinical / unstaged

Compare the share prices of listed companies in Asthma →

Total attributable cost

$107.9B

$4,333/patient

Drug spend

Not yet sourced

How this is calculated ↗

All severities, current asthma (2021 estimate) · US

The Asthma pipeline

Key trial results for every approved and late-stage drug: Asthma results by drug.

← all assets